{Reference Type}: Journal Article
{Title}: Mitochondrial Quality Control in Ovarian Function: From Mechanisms to Therapeutic Strategies.
{Author}: Wang X;Liu Y;Wang J;Lu X;Guo Z;Lv S;Sun Z;Gao T;Gao F;Yuan J;
{Journal}: Reprod Sci
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jul 9
{Factor}: 2.924
{DOI}: 10.1007/s43032-024-01634-4
{Abstract}: Mitochondrial quality control plays a critical role in cytogenetic development by regulating various cell-death pathways and modulating the release of reactive oxygen species (ROS). Dysregulated mitochondrial quality control can lead to a broad spectrum of diseases, including reproductive disorders, particularly female infertility. Ovarian insufficiency is a significant contributor to female infertility, given its high prevalence, complex pathogenesis, and profound impact on women's health. Understanding the pathogenesis of ovarian insufficiency and devising treatment strategies based on this understanding are crucial. Oocytes and granulosa cells (GCs) are the primary ovarian cell types, with GCs regulated by oocytes, fulfilling their specific energy requirements prior to ovulation. Dysregulation of mitochondrial quality control through gene knockout or external stimuli can precipitate apoptosis, inflammatory responses, or ferroptosis in both oocytes and GCs, exacerbating ovarian insufficiency. This review aimed to delineate the regulatory mechanisms of mitochondrial quality control in GCs and oocytes during ovarian development. This study highlights the adverse consequences of dysregulated mitochondrial quality control on GCs and oocyte development and proposes therapeutic interventions for ovarian insufficiency based on mitochondrial quality control. These insights provide a foundation for future clinical approaches for treating ovarian insufficiency.